Verona Pharma has agreed a new $400 million debt facility with Oxford Finance and Hercules Capital designed to help the company navigate the possible approval and launch of ensifentrine ...

This week in Verona, capital of the Nazi manipulated Fascist “Republic,” Ciano was condemned to death by a puppet court, shot next day. Contact us at [email protected] ...

Verona Pharma (NASDAQ:VRNA – Get Free Report) was upgraded by investment analysts at Roth Capital to a “strong-buy” rating in a report released on Friday,Zacks.com reports.